Progestin Therapy for Endometriosis: How It Works
SaveProgestin therapy eases endometriosis by suppressing the hormone signals that drive the tissue, so it bleeds less and causes less pain. Progestins such as dienogest are a common first-line option, taken as a daily pill or via an IUD. They control symptoms rather than curing the condition, and side effects vary.
Last updated: July 2026
How does progestin treat endometriosis?
Progestins work by quieting the hormonal cycle that feeds endometriosis. Endometriosis tissue responds to estrogen, growing and bleeding with each cycle, which drives pain and inflammation. Progestins counter that effect: they thin the endometriosis-like tissue, suppress ovulation in many people, and reduce or stop menstrual bleeding. According to the 2022 ESHRE guideline, progestogens are recommended as a first-line hormonal treatment for endometriosis-associated pain 1Ref 1Becker CM, et al. (ESHRE) (2022).ESHRE guideline: endometriosis.Supports that progestogens are recommended as a first-line hormonal treatment for endometriosis-associated pain, reduce pain over months, and can be used across the reproductive lifespan with bone monitoring for some regimens.. The aim is symptom control rather than cure, since the tissue can become active again if treatment stops. Relief usually builds over weeks to a few months rather than arriving overnight.
What is dienogest, and how is it used?
Dienogest is a progestin studied specifically for endometriosis and used widely around the world, sometimes under the brand name Visanne. Taken as a daily pill, it lowers estrogen modestly and calms endometriosis tissue while being gentler on bone density than older, stronger suppressive drugs. Other progestins, such as norethindrone acetate or the levonorgestrel intrauterine device, work through the same broad mechanism. According to NICE, hormonal treatment including progestogens is offered to manage endometriosis pain, with the choice often coming down to side effects and personal preference 2Ref 2National Institute for Health and Care Excellence (2024).Endometriosis: diagnosis and management (NG73).Supports offering hormonal treatment including progestogens to manage endometriosis pain, with the choice guided by side effects and preference.. The hormonal IUD delivers progestin locally, which can mean lighter periods and fewer whole-body effects. Having several delivery options means a poor fit with one form is not the end of the road.
How well does progestin therapy work?
Progestin therapy reduces endometriosis pain for many people, though not everyone responds. Trials of progestins report meaningful drops in painful periods, pelvic pain, and pain with sex over several months of use 1Ref 1Becker CM, et al. (ESHRE) (2022).ESHRE guideline: endometriosis.Supports that progestogens are recommended as a first-line hormonal treatment for endometriosis-associated pain, reduce pain over months, and can be used across the reproductive lifespan with bone monitoring for some regimens.. When progestins are not enough, other hormonal options exist: a 2017 trial found that elagolix, an oral drug that blocks the hormone signals driving endometriosis, reduced pain compared with a placebo 3Ref 3Taylor HS, Giudice LC, Lessey BA, et al. (2017).Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist.Supports that elagolix, an oral GnRH antagonist, reduced endometriosis-associated pain compared with placebo, offering a hormonal alternative when progestins are insufficient.. According to ACOG, hormonal treatment is a mainstay of managing endometriosis and is often continued long term to keep symptoms in check 4Ref 4American College of Obstetricians and Gynecologists (2010).Practice bulletin no. 114: management of endometriosis.Supports that hormonal treatment is a mainstay of managing endometriosis and is often continued long term to keep symptoms in check.. Because endometriosis affects roughly 1 in 10 women of reproductive age — around 10%, or about 190 million worldwide — having several effective options genuinely matters 5Ref 5World Health Organization (2025).Endometriosis (fact sheet).Supports that endometriosis affects roughly 10% (about 190 million) of reproductive-age women and girls, underscoring the need for several effective treatment options.. No single drug suits everyone, which is why the menu is worth knowing.
What are the side effects and trade-offs?
Progestins are generally well tolerated, but they carry trade-offs worth weighing. Irregular spotting is the most common early effect, and some people notice mood changes, breast tenderness, or lower libido. Weight gain is a frequent worry, yet a Cochrane review found only limited evidence that progestin-only methods cause meaningful weight change, with average differences under about 2 kg across 6 to 12 months 6Ref 6Lopez LM, Ramesh S, Chen M, et al. (2016).Progestin-only contraceptives: effects on weight.Supports that evidence for meaningful weight gain from progestin-only methods is limited, with average changes under about 2 kg over 6 to 12 months.. Progestins can be used across much of the reproductive lifespan — from adolescence, where they help manage early endometriosis, through the perimenopausal years — though bone health is monitored with some longer-term regimens 1Ref 1Becker CM, et al. (ESHRE) (2022).ESHRE guideline: endometriosis.Supports that progestogens are recommended as a first-line hormonal treatment for endometriosis-associated pain, reduce pain over months, and can be used across the reproductive lifespan with bone monitoring for some regimens.. Because progestins prevent pregnancy in most people, they are not an option while actively trying to conceive. Weighing these trade-offs against the relief they offer is the heart of the decision.
When a clinician helps you weigh options
Choosing a hormonal treatment for endometriosis works best as a shared decision. A gynecologist can match a progestin — pill or IUD — to your symptoms, side-effect tolerance, and pregnancy plans, and adjust course if the first choice does not fit. Reviewing how treatment is working every few months, rather than pushing through side effects silently, keeps the plan on track. Gale can help you prepare for that conversation. If medication is not enough, understanding how surgeons weigh excision versus ablation or approaches that avoid surgery rounds out the options.
Common questions
Related
Hormonal health
Pelvic Floor Therapy for Endometriosis PainHormonal health
Methimazole for Graves' Disease: What to ExpectHormonal health
Radioactive Iodine for Thyroid: What Happens
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When endometriosis symptoms need a closer look
- —Pain that continues or worsens after a few months of hormonal treatment is a reason to seek clinician review.
- —New or worsening low mood, or thoughts of self-harm, while on hormonal treatment is a reason to seek prompt clinician review; if you are thinking about harming yourself, call or text 988.
- —Heavy or prolonged bleeding with fatigue or dizziness is a reason to have your symptoms and iron assessed.
- —Sudden, severe pelvic pain with nausea or fainting warrants urgent, same-day evaluation.
This article is general health education, not medical advice. Whether a progestin, and which one, suits your endometriosis is a decision to make with a gynecologist or clinician who knows your history.
References
- 1.Becker CM, et al. (ESHRE) (2022). ESHRE guideline: endometriosis. Human Reproduction Open. doi:10.1093/hropen/hoac009 ✓Supports that progestogens are recommended as a first-line hormonal treatment for endometriosis-associated pain, reduce pain over months, and can be used across the reproductive lifespan with bone monitoring for some regimens.
- 2.National Institute for Health and Care Excellence (2024). Endometriosis: diagnosis and management (NG73). National Institute for Health and Care Excellence (NICE). link ✓Supports offering hormonal treatment including progestogens to manage endometriosis pain, with the choice guided by side effects and preference.
- 3.Taylor HS, Giudice LC, Lessey BA, et al. (2017). Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. New England Journal of Medicine. doi:10.1056/NEJMoa1700089 ✓Supports that elagolix, an oral GnRH antagonist, reduced endometriosis-associated pain compared with placebo, offering a hormonal alternative when progestins are insufficient.
- 4.American College of Obstetricians and Gynecologists (2010). Practice bulletin no. 114: management of endometriosis. Obstetrics & Gynecology. doi:10.1097/AOG.0b013e3181e8b073 ✓Supports that hormonal treatment is a mainstay of managing endometriosis and is often continued long term to keep symptoms in check.
- 5.World Health Organization (2025). Endometriosis (fact sheet). World Health Organization (WHO). link ✓Supports that endometriosis affects roughly 10% (about 190 million) of reproductive-age women and girls, underscoring the need for several effective treatment options.
- 6.Lopez LM, Ramesh S, Chen M, et al. (2016). Progestin-only contraceptives: effects on weight. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008815.pub4 ✓Supports that evidence for meaningful weight gain from progestin-only methods is limited, with average changes under about 2 kg over 6 to 12 months.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy